The European Commission has given a CE mark to Bausch + Lomb for the Stellaris Elite vision enhancement system with the Vitesse hypersonic open-port vitrectomy system, Valeant Pharmaceuticals announced in a press release.
The surgical platform is now available throughout Europe including Iceland, Liechtenstein, Norway and Switzerland, in addition to the 28 European Union countries. It is already available in the United States.
It is the first phacoemulsification platform available with adaptive fluidics, which combines aspiration control with predictive infusion management, the release said.
Uncategorized